arrow_back Trending Legislation
Share share

Ehlers-Danlos Syndrome Awareness Month: Support for Research and Knowledge

This House Resolution supports designating May as Ehlers-Danlos Syndrome Awareness Month. The goal is to increase public knowledge of this rare genetic disease, which can lead to earlier diagnosis and improved quality of life for affected individuals, as well as encourage further research into treatments.
Key points
Increasing public awareness of Ehlers-Danlos Syndrome, potentially leading to earlier diagnosis.
Supporting scientific research and funding to find treatments and a cure for the disease.
Honoring individuals bravely suffering from Ehlers-Danlos Syndrome.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Expressing support for the designation of May as Ehlers-Danlos Syndrome Awareness Month to increase the knowledge of this little-known, potentially fatal, genetic disease.
Print number: HRES 419
Sponsor: Rep. Ruppersberger, C. A. Dutch [D-MD-2]
Process start date: 2023-05-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Ehlers-Danlos Syndrome Awareness Month: Support for Research and Knowledge

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 419.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-17.

What are the main provisions?

Key points include:

  • Increasing public awareness of Ehlers-Danlos Syndrome, potentially leading to earlier diagnosis.
  • Supporting scientific research and funding to find treatments and a cure for the disease.
  • Honoring individuals bravely suffering from Ehlers-Danlos Syndrome.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Ruppersberger, C. A. Dutch [D-MD-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HRES 419

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health